FOSRENOL is indicated to reduce serum phosphate in patients with end stage renal disease (ESRD).
Please click here for Full Prescribing Information for FOSRENOL (lanthanum carbonate).
FOSRENOL® is registered with the US Patent and Trademark Office.
FOSRENOL On Track™ is a trademark of Shire LLC.
This site is strictly intended for US residents and is governed solely by US laws and governmental regulations.
©2014 Shire US Inc. Wayne, PA 19087. 1-800-828-2088. All rights reserved.
No personal information (including e-mail addresses) will be collected from this feature.